nodes	percent_of_prediction	percent_of_DWPC	metapath
Lomefloxacin—TOP2A—hematologic cancer	0.294	1	CbGaD
Lomefloxacin—TOP2A—Idarubicin—hematologic cancer	0.0821	0.169	CbGbCtD
Lomefloxacin—TOP2A—Daunorubicin—hematologic cancer	0.0581	0.119	CbGbCtD
Lomefloxacin—TOP2A—Teniposide—hematologic cancer	0.0505	0.104	CbGbCtD
Lomefloxacin—TOP2A—Mitoxantrone—hematologic cancer	0.0353	0.0726	CbGbCtD
Lomefloxacin—TOP2A—Epirubicin—hematologic cancer	0.0286	0.0588	CbGbCtD
Lomefloxacin—ABCC2—Daunorubicin—hematologic cancer	0.0238	0.049	CbGbCtD
Lomefloxacin—TOP2A—Etoposide—hematologic cancer	0.0223	0.0458	CbGbCtD
Lomefloxacin—CYP1A2—Anagrelide—hematologic cancer	0.0219	0.045	CbGbCtD
Lomefloxacin—TOP2A—Doxorubicin—hematologic cancer	0.0152	0.0312	CbGbCtD
Lomefloxacin—CYP1A2—Carmustine—hematologic cancer	0.0115	0.0236	CbGbCtD
Lomefloxacin—ABCC2—Irinotecan—hematologic cancer	0.0114	0.0235	CbGbCtD
Lomefloxacin—ABCC2—Vinblastine—hematologic cancer	0.0101	0.0208	CbGbCtD
Lomefloxacin—ABCC2—Vincristine—hematologic cancer	0.00997	0.0205	CbGbCtD
Lomefloxacin—CYP1A2—Methoxsalen—hematologic cancer	0.00977	0.0201	CbGbCtD
Lomefloxacin—ABCC2—Cisplatin—hematologic cancer	0.0093	0.0191	CbGbCtD
Lomefloxacin—CYP1A2—Bortezomib—hematologic cancer	0.00929	0.0191	CbGbCtD
Lomefloxacin—ABCC2—Etoposide—hematologic cancer	0.00914	0.0188	CbGbCtD
Lomefloxacin—CYP1A2—Daunorubicin—hematologic cancer	0.00889	0.0183	CbGbCtD
Lomefloxacin—CYP1A2—Alitretinoin—hematologic cancer	0.00871	0.0179	CbGbCtD
Lomefloxacin—CYP1A2—Thalidomide—hematologic cancer	0.00809	0.0166	CbGbCtD
Lomefloxacin—ABCC2—Dexamethasone—hematologic cancer	0.00751	0.0154	CbGbCtD
Lomefloxacin—CYP1A2—Dacarbazine—hematologic cancer	0.00696	0.0143	CbGbCtD
Lomefloxacin—CYP1A2—Imatinib—hematologic cancer	0.00681	0.014	CbGbCtD
Lomefloxacin—ABCC2—Doxorubicin—hematologic cancer	0.00623	0.0128	CbGbCtD
Lomefloxacin—ABCC2—Methotrexate—hematologic cancer	0.00604	0.0124	CbGbCtD
Lomefloxacin—CYP1A2—Dasatinib—hematologic cancer	0.00547	0.0112	CbGbCtD
Lomefloxacin—CYP1A2—Etoposide—hematologic cancer	0.00341	0.007	CbGbCtD
Lomefloxacin—Trovafloxacin—TOP2A—hematologic cancer	0.00066	0.196	CrCbGaD
Lomefloxacin—Moxifloxacin—TOP2A—hematologic cancer	0.0005	0.148	CrCbGaD
Lomefloxacin—Pefloxacin—TOP2A—hematologic cancer	0.000365	0.108	CrCbGaD
Lomefloxacin—Enoxacin—TOP2A—hematologic cancer	0.000341	0.101	CrCbGaD
Lomefloxacin—Sparfloxacin—TOP2A—hematologic cancer	0.000314	0.0932	CrCbGaD
Lomefloxacin—TOP2A—Nilotinib—Imatinib—hematologic cancer	0.000259	0.0778	CbGdCrCtD
Lomefloxacin—Levofloxacin—TOP2A—hematologic cancer	0.000221	0.0656	CrCbGaD
Lomefloxacin—Ofloxacin—TOP2A—hematologic cancer	0.000221	0.0656	CrCbGaD
Lomefloxacin—Ciprofloxacin—TOP2A—hematologic cancer	0.000214	0.0633	CrCbGaD
Lomefloxacin—Norfloxacin—TOP2A—hematologic cancer	0.000179	0.0532	CrCbGaD
Lomefloxacin—TOP2A—Topotecan—Irinotecan—hematologic cancer	0.000144	0.0432	CbGdCrCtD
Lomefloxacin—Gatifloxacin—ALB—hematologic cancer	0.000143	0.0426	CrCbGaD
Lomefloxacin—TOP2A—Etoposide—Teniposide—hematologic cancer	0.000143	0.0429	CbGdCrCtD
Lomefloxacin—TOP2A—Vindesine—Vinorelbine—hematologic cancer	0.000128	0.0386	CbGdCrCtD
Lomefloxacin—TOP2A—blood—hematologic cancer	0.000128	0.108	CbGeAlD
Lomefloxacin—TOP2A—bone marrow—hematologic cancer	0.000124	0.104	CbGeAlD
Lomefloxacin—TOP2A—lung—hematologic cancer	0.000112	0.0942	CbGeAlD
Lomefloxacin—TOP2A—Podofilox—Teniposide—hematologic cancer	0.000109	0.0327	CbGdCrCtD
Lomefloxacin—TOP2A—testis—hematologic cancer	0.000106	0.0889	CbGeAlD
Lomefloxacin—TOP2A—Vindesine—Vinblastine—hematologic cancer	0.000103	0.0308	CbGdCrCtD
Lomefloxacin—TOP2A—Vindesine—Vincristine—hematologic cancer	0.000103	0.0308	CbGdCrCtD
Lomefloxacin—TOP2A—Floxuridine—Pentostatin—hematologic cancer	9.89e-05	0.0297	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Daunorubicin—hematologic cancer	9.7e-05	0.0291	CbGdCrCtD
Lomefloxacin—TOP2A—Epirubicin—Daunorubicin—hematologic cancer	9.7e-05	0.0291	CbGdCrCtD
Lomefloxacin—TOP2A—Doxorubicin—Daunorubicin—hematologic cancer	9.7e-05	0.0291	CbGdCrCtD
Lomefloxacin—CYP1A2—hematopoietic system—hematologic cancer	9.27e-05	0.0778	CbGeAlD
Lomefloxacin—Sparfloxacin—ABCB1—hematologic cancer	8.93e-05	0.0265	CrCbGaD
Lomefloxacin—ABCC2—blood—hematologic cancer	8.75e-05	0.0735	CbGeAlD
Lomefloxacin—TOP2A—Menadione—Thalidomide—hematologic cancer	8.25e-05	0.0248	CbGdCrCtD
Lomefloxacin—TOP2A—lymph node—hematologic cancer	7.67e-05	0.0645	CbGeAlD
Lomefloxacin—TOP2A—Cladribine—Pentostatin—hematologic cancer	7.49e-05	0.0225	CbGdCrCtD
Lomefloxacin—TOP2A—Doxorubicin—Idarubicin—hematologic cancer	7.35e-05	0.0221	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Idarubicin—hematologic cancer	7.35e-05	0.0221	CbGdCrCtD
Lomefloxacin—TOP2A—Epirubicin—Idarubicin—hematologic cancer	7.35e-05	0.0221	CbGdCrCtD
Lomefloxacin—ABCC2—testis—hematologic cancer	7.23e-05	0.0608	CbGeAlD
Lomefloxacin—TOP2A—Vincristine—Vinorelbine—hematologic cancer	6.93e-05	0.0208	CbGdCrCtD
Lomefloxacin—SLC22A5—blood—hematologic cancer	6.78e-05	0.0569	CbGeAlD
Lomefloxacin—TOP2A—Cladribine—Clofarabine—hematologic cancer	6.67e-05	0.0201	CbGdCrCtD
Lomefloxacin—TOP2A—Vinorelbine—Vinblastine—hematologic cancer	6.48e-05	0.0195	CbGdCrCtD
Lomefloxacin—TOP2A—Vinorelbine—Vincristine—hematologic cancer	6.48e-05	0.0195	CbGdCrCtD
Lomefloxacin—TOP2A—Podofilox—Etoposide—hematologic cancer	6.47e-05	0.0194	CbGdCrCtD
Lomefloxacin—TOP2A—Teniposide—Etoposide—hematologic cancer	6.47e-05	0.0194	CbGdCrCtD
Lomefloxacin—Levofloxacin—ABCB1—hematologic cancer	6.29e-05	0.0186	CrCbGaD
Lomefloxacin—TOP2A—Cladribine—Nelarabine—hematologic cancer	6.28e-05	0.0189	CbGdCrCtD
Lomefloxacin—CYP1A2—blood—hematologic cancer	6.14e-05	0.0516	CbGeAlD
Lomefloxacin—Ciprofloxacin—ABCB1—hematologic cancer	6.07e-05	0.018	CrCbGaD
Lomefloxacin—TOP2A—Floxuridine—Cladribine—hematologic cancer	5.95e-05	0.0179	CbGdCrCtD
Lomefloxacin—SLC22A5—lung—hematologic cancer	5.94e-05	0.0499	CbGeAlD
Lomefloxacin—TOP2A—Clofarabine—Nelarabine—hematologic cancer	5.8e-05	0.0174	CbGdCrCtD
Lomefloxacin—SLC22A5—testis—hematologic cancer	5.61e-05	0.0471	CbGeAlD
Lomefloxacin—TOP2A—Vinblastine—Vinorelbine—hematologic cancer	5.57e-05	0.0167	CbGdCrCtD
Lomefloxacin—TOP2A—Vincristine—Vinblastine—hematologic cancer	5.54e-05	0.0166	CbGdCrCtD
Lomefloxacin—CYP1A2—lung—hematologic cancer	5.38e-05	0.0452	CbGeAlD
Lomefloxacin—TOP2A—Cytarabine—Clofarabine—hematologic cancer	5.25e-05	0.0158	CbGdCrCtD
Lomefloxacin—ABCC2—lymph node—hematologic cancer	5.24e-05	0.0441	CbGeAlD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	4.97e-05	0.00145	CbGpPWpGaD
Lomefloxacin—TOP2A—Cytarabine—Nelarabine—hematologic cancer	4.94e-05	0.0148	CbGdCrCtD
Lomefloxacin—ABCC2—NRF2 pathway—HGF—hematologic cancer	4.93e-05	0.00144	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—GSTM1—hematologic cancer	4.93e-05	0.00144	CbGpPWpGaD
Lomefloxacin—TOP2A—Cladribine—Fludarabine—hematologic cancer	4.9e-05	0.0147	CbGdCrCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—FAS—hematologic cancer	4.89e-05	0.00142	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—NUP98—hematologic cancer	4.81e-05	0.0014	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—FOXM1—hematologic cancer	4.78e-05	0.00139	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—H3F3B—hematologic cancer	4.78e-05	0.00139	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	4.74e-05	0.00138	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—hematologic cancer	4.69e-05	0.00137	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	4.67e-05	0.00136	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—NUP214—hematologic cancer	4.64e-05	0.00135	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—NPM1—hematologic cancer	4.6e-05	0.00134	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—MTR—hematologic cancer	4.58e-05	0.00134	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	4.55e-05	0.00133	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—BAX—hematologic cancer	4.55e-05	0.00132	CbGpPWpGaD
Lomefloxacin—TOP2A—Clofarabine—Fludarabine—hematologic cancer	4.53e-05	0.0136	CbGdCrCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—hematologic cancer	4.52e-05	0.00132	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND3—hematologic cancer	4.52e-05	0.00132	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	4.5e-05	0.00131	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	4.48e-05	0.00131	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	4.46e-05	0.0013	CbGpPWpGaD
Lomefloxacin—TOP2A—Vinblastine—Vincristine—hematologic cancer	4.45e-05	0.0134	CbGdCrCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	4.43e-05	0.00129	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCC3—hematologic cancer	4.38e-05	0.00128	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTT1—hematologic cancer	4.36e-05	0.00127	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	4.36e-05	0.00127	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	4.36e-05	0.00127	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—hematologic cancer	4.36e-05	0.00127	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CDK4—hematologic cancer	4.3e-05	0.00125	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—NUP98—hematologic cancer	4.3e-05	0.00125	CbGpPWpGaD
Lomefloxacin—TOP2A—Clofarabine—Cytarabine—hematologic cancer	4.28e-05	0.0129	CbGdCrCtD
Lomefloxacin—ABCC2—NRF2 pathway—PDGFB—hematologic cancer	4.24e-05	0.00124	CbGpPWpGaD
Lomefloxacin—TOP2A—Azacitidine—Pentostatin—hematologic cancer	4.22e-05	0.0127	CbGdCrCtD
Lomefloxacin—TOP2A—Clofarabine—Cladribine—hematologic cancer	4.17e-05	0.0125	CbGdCrCtD
Lomefloxacin—TOP2A—Cell Cycle—NUP214—hematologic cancer	4.14e-05	0.00121	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—SMC1A—hematologic cancer	4.09e-05	0.00119	CbGpPWpGaD
Lomefloxacin—SLC22A5—lymph node—hematologic cancer	4.06e-05	0.0341	CbGeAlD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ANXA2—hematologic cancer	4.05e-05	0.00118	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ATP4A—hematologic cancer	4.05e-05	0.00118	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SGK1—hematologic cancer	4.05e-05	0.00118	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	4.02e-05	0.00117	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—H3F3A—hematologic cancer	4.01e-05	0.00117	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1B—hematologic cancer	4.01e-05	0.00117	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	4e-05	0.00117	CbGpPWpGaD
Lomefloxacin—TOP2A—Gemcitabine—Cytarabine—hematologic cancer	3.96e-05	0.0119	CbGdCrCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	3.93e-05	0.00115	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	3.91e-05	0.00114	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDK2—hematologic cancer	3.89e-05	0.00113	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—CREB1—hematologic cancer	3.86e-05	0.00112	CbGpPWpGaD
Lomefloxacin—TOP2A—Cytarabine—Fludarabine—hematologic cancer	3.85e-05	0.0116	CbGdCrCtD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—hematologic cancer	3.82e-05	0.00111	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—MLH1—hematologic cancer	3.82e-05	0.00111	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—NUP98—hematologic cancer	3.78e-05	0.0011	CbGpPWpGaD
Lomefloxacin—TOP2A—Azacitidine—Clofarabine—hematologic cancer	3.76e-05	0.0113	CbGdCrCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—hematologic cancer	3.76e-05	0.0011	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	3.73e-05	0.00109	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN1A—hematologic cancer	3.7e-05	0.00108	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ADCY7—hematologic cancer	3.67e-05	0.00107	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—hematologic cancer	3.67e-05	0.00107	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—SMC1A—hematologic cancer	3.66e-05	0.00107	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	3.64e-05	0.00106	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—NUP214—hematologic cancer	3.64e-05	0.00106	CbGpPWpGaD
Lomefloxacin—TOP2A—Cytarabine—Gemcitabine—hematologic cancer	3.64e-05	0.0109	CbGdCrCtD
Lomefloxacin—TOP2A—Cell Cycle—H3F3A—hematologic cancer	3.58e-05	0.00104	CbGpPWpGaD
Lomefloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—hematologic cancer	3.58e-05	0.00104	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCG2—hematologic cancer	3.57e-05	0.00104	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	3.55e-05	0.00103	CbGpPWpGaD
Lomefloxacin—TOP2A—Azacitidine—Nelarabine—hematologic cancer	3.54e-05	0.0106	CbGdCrCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—HSP90AA1—hematologic cancer	3.37e-05	0.000983	CbGpPWpGaD
Lomefloxacin—TOP2A—Idarubicin—Epirubicin—hematologic cancer	3.37e-05	0.0101	CbGdCrCtD
Lomefloxacin—TOP2A—Doxorubicin—Epirubicin—hematologic cancer	3.37e-05	0.0101	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Epirubicin—hematologic cancer	3.37e-05	0.0101	CbGdCrCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	3.37e-05	0.000983	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDK6—hematologic cancer	3.36e-05	0.00098	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	3.32e-05	0.000968	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTO1—hematologic cancer	3.29e-05	0.000958	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTO1—hematologic cancer	3.24e-05	0.000945	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND2—hematologic cancer	3.24e-05	0.000943	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RB1—hematologic cancer	3.2e-05	0.000932	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCC3—hematologic cancer	3.2e-05	0.000932	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—TFRC—hematologic cancer	3.18e-05	0.000926	CbGpPWpGaD
Lomefloxacin—TOP2A—Epirubicin—Doxorubicin—hematologic cancer	3.12e-05	0.00938	CbGdCrCtD
Lomefloxacin—TOP2A—Idarubicin—Doxorubicin—hematologic cancer	3.12e-05	0.00938	CbGdCrCtD
Lomefloxacin—TOP2A—Daunorubicin—Doxorubicin—hematologic cancer	3.12e-05	0.00938	CbGdCrCtD
Lomefloxacin—CYP1A2—Biological oxidations—UGT1A1—hematologic cancer	3.09e-05	0.000901	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MAP2K1—hematologic cancer	3.07e-05	0.000893	CbGpPWpGaD
Lomefloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—hematologic cancer	3.06e-05	0.000893	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—UGT1A1—hematologic cancer	3.05e-05	0.000889	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PHYH—hematologic cancer	3.04e-05	0.000886	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	3.03e-05	0.000884	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTP1—hematologic cancer	3.02e-05	0.00088	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—HSP90AA1—hematologic cancer	3.02e-05	0.000879	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	2.97e-05	0.000866	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.93e-05	0.000853	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2B—hematologic cancer	2.9e-05	0.000845	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	2.89e-05	0.000843	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CCND2—hematologic cancer	2.89e-05	0.000843	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	2.89e-05	0.000842	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	2.8e-05	0.000816	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	2.79e-05	0.000814	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SMPD3—hematologic cancer	2.78e-05	0.000811	CbGpPWpGaD
Lomefloxacin—CYP1A2—Phase II conjugation—GSTM1—hematologic cancer	2.78e-05	0.000809	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—JUN—hematologic cancer	2.77e-05	0.000808	CbGpPWpGaD
Lomefloxacin—TOP2A—Azacitidine—Fludarabine—hematologic cancer	2.76e-05	0.0083	CbGdCrCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.76e-05	0.000805	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—hematologic cancer	2.74e-05	0.000799	CbGpPWpGaD
Lomefloxacin—SLC22A5—SLC-mediated transmembrane transport—ALB—hematologic cancer	2.74e-05	0.000799	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	2.73e-05	0.000796	CbGpPWpGaD
Lomefloxacin—CYP1A2—Tryptophan metabolism—MDM2—hematologic cancer	2.73e-05	0.000795	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—PTEN—hematologic cancer	2.68e-05	0.000781	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2.68e-05	0.000781	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—MTR—hematologic cancer	2.68e-05	0.000781	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CYCS—hematologic cancer	2.67e-05	0.000777	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	2.66e-05	0.000776	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—NUP214—hematologic cancer	2.66e-05	0.000776	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—MAPK8—hematologic cancer	2.62e-05	0.000764	CbGpPWpGaD
Lomefloxacin—TOP2A—Azacitidine—Cytarabine—hematologic cancer	2.61e-05	0.00784	CbGdCrCtD
Lomefloxacin—TOP2A—Azacitidine—Gemcitabine—hematologic cancer	2.61e-05	0.00784	CbGdCrCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCG2—hematologic cancer	2.61e-05	0.00076	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2B—hematologic cancer	2.59e-05	0.000756	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	2.59e-05	0.000755	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—EP300—hematologic cancer	2.56e-05	0.000745	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTT1—hematologic cancer	2.55e-05	0.000743	CbGpPWpGaD
Lomefloxacin—TOP2A—Azacitidine—Cladribine—hematologic cancer	2.54e-05	0.00764	CbGdCrCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	2.52e-05	0.000735	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—BIRC5—hematologic cancer	2.5e-05	0.000729	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—hematologic cancer	2.49e-05	0.000726	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—hematologic cancer	2.49e-05	0.000726	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—hematologic cancer	2.45e-05	0.000713	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—hematologic cancer	2.44e-05	0.00071	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	2.39e-05	0.000696	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—hematologic cancer	2.37e-05	0.000691	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—TFRC—hematologic cancer	2.32e-05	0.000677	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	2.32e-05	0.000677	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	2.32e-05	0.000675	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1A—hematologic cancer	2.3e-05	0.00067	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK2—hematologic cancer	2.3e-05	0.000669	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—BIRC5—hematologic cancer	2.24e-05	0.000652	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ABCB1—hematologic cancer	2.23e-05	0.000649	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—hematologic cancer	2.19e-05	0.000637	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EP300—hematologic cancer	2.19e-05	0.000637	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—hematologic cancer	2.17e-05	0.000632	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—TERT—hematologic cancer	2.17e-05	0.000632	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	2.16e-05	0.00063	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	2.15e-05	0.000625	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—hematologic cancer	2.13e-05	0.00062	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—SRC—hematologic cancer	2.13e-05	0.00062	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—hematologic cancer	2.07e-05	0.000604	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDK2—hematologic cancer	2.05e-05	0.000598	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—hematologic cancer	2.05e-05	0.000596	CbGpPWpGaD
Lomefloxacin—ABCC2—NRF2 pathway—TGFB1—hematologic cancer	2.01e-05	0.000586	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.97e-05	0.000574	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—GBA—hematologic cancer	1.96e-05	0.000571	CbGpPWpGaD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.95e-05	0.000568	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—ATM—hematologic cancer	1.95e-05	0.000568	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—CDK4—hematologic cancer	1.94e-05	0.000565	CbGpPWpGaD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	1.91e-05	0.000556	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—hematologic cancer	1.91e-05	0.000555	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—hematologic cancer	1.9e-05	0.000554	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—RB1—hematologic cancer	1.89e-05	0.00055	CbGpPWpGaD
Lomefloxacin—TOP2A—Circadian rythm related genes—TP53—hematologic cancer	1.83e-05	0.000533	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—hematologic cancer	1.78e-05	0.000517	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—hematologic cancer	1.78e-05	0.000517	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTP1—hematologic cancer	1.77e-05	0.000515	CbGpPWpGaD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—hematologic cancer	1.76e-05	0.000513	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTP1—hematologic cancer	1.74e-05	0.000508	CbGpPWpGaD
Lomefloxacin—Dysgeusia—Methotrexate—hematologic cancer	1.7e-05	9.61e-05	CcSEcCtD
Lomefloxacin—Asthenia—Etoposide—hematologic cancer	1.7e-05	9.59e-05	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Prednisone—hematologic cancer	1.7e-05	9.58e-05	CcSEcCtD
Lomefloxacin—Oedema—Prednisone—hematologic cancer	1.7e-05	9.58e-05	CcSEcCtD
Lomefloxacin—Decreased appetite—Dexamethasone—hematologic cancer	1.7e-05	9.56e-05	CcSEcCtD
Lomefloxacin—Decreased appetite—Betamethasone—hematologic cancer	1.7e-05	9.56e-05	CcSEcCtD
Lomefloxacin—Nausea—Irinotecan—hematologic cancer	1.69e-05	9.55e-05	CcSEcCtD
Lomefloxacin—Nausea—Mitoxantrone—hematologic cancer	1.69e-05	9.55e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—RB1—hematologic cancer	1.69e-05	0.000492	CbGpPWpGaD
Lomefloxacin—Back pain—Methotrexate—hematologic cancer	1.68e-05	9.49e-05	CcSEcCtD
Lomefloxacin—Fatigue—Betamethasone—hematologic cancer	1.68e-05	9.49e-05	CcSEcCtD
Lomefloxacin—Fatigue—Dexamethasone—hematologic cancer	1.68e-05	9.49e-05	CcSEcCtD
Lomefloxacin—Chills—Epirubicin—hematologic cancer	1.68e-05	9.46e-05	CcSEcCtD
Lomefloxacin—Pruritus—Etoposide—hematologic cancer	1.68e-05	9.46e-05	CcSEcCtD
Lomefloxacin—TOP2A—Circadian rythm related genes—IL6—hematologic cancer	1.68e-05	0.000488	CbGpPWpGaD
Lomefloxacin—Shock—Prednisone—hematologic cancer	1.67e-05	9.43e-05	CcSEcCtD
Lomefloxacin—Arrhythmia—Epirubicin—hematologic cancer	1.67e-05	9.42e-05	CcSEcCtD
Lomefloxacin—Visual impairment—Doxorubicin—hematologic cancer	1.67e-05	9.4e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—hematologic cancer	1.66e-05	0.000483	CbGpPWpGaD
Lomefloxacin—Tachycardia—Prednisone—hematologic cancer	1.66e-05	9.35e-05	CcSEcCtD
Lomefloxacin—Skin disorder—Prednisone—hematologic cancer	1.65e-05	9.31e-05	CcSEcCtD
Lomefloxacin—Nausea—Gemcitabine—hematologic cancer	1.65e-05	9.3e-05	CcSEcCtD
Lomefloxacin—Vomiting—Cisplatin—hematologic cancer	1.65e-05	9.28e-05	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Prednisone—hematologic cancer	1.64e-05	9.26e-05	CcSEcCtD
Lomefloxacin—Erythema multiforme—Doxorubicin—hematologic cancer	1.64e-05	9.23e-05	CcSEcCtD
Lomefloxacin—Rash—Cisplatin—hematologic cancer	1.63e-05	9.2e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Cisplatin—hematologic cancer	1.63e-05	9.19e-05	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	1.63e-05	0.000474	CbGpPWpGaD
Lomefloxacin—CYP1A2—Biological oxidations—GSTM1—hematologic cancer	1.62e-05	0.000473	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Etoposide—hematologic cancer	1.62e-05	9.15e-05	CcSEcCtD
Lomefloxacin—Anorexia—Prednisone—hematologic cancer	1.62e-05	9.13e-05	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Methotrexate—hematologic cancer	1.61e-05	9.1e-05	CcSEcCtD
Lomefloxacin—Tinnitus—Doxorubicin—hematologic cancer	1.61e-05	9.1e-05	CcSEcCtD
Lomefloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	1.61e-05	0.000469	CbGpPWpGaD
Lomefloxacin—Anaemia—Methotrexate—hematologic cancer	1.61e-05	9.07e-05	CcSEcCtD
Lomefloxacin—Feeling abnormal—Dexamethasone—hematologic cancer	1.61e-05	9.07e-05	CcSEcCtD
Lomefloxacin—Feeling abnormal—Betamethasone—hematologic cancer	1.61e-05	9.07e-05	CcSEcCtD
Lomefloxacin—Flushing—Doxorubicin—hematologic cancer	1.61e-05	9.06e-05	CcSEcCtD
Lomefloxacin—Flatulence—Epirubicin—hematologic cancer	1.6e-05	9.05e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metapathway biotransformation—GSTM1—hematologic cancer	1.6e-05	0.000467	CbGpPWpGaD
Lomefloxacin—Tension—Epirubicin—hematologic cancer	1.6e-05	9.01e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—FHL2—hematologic cancer	1.6e-05	0.000466	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Dexamethasone—hematologic cancer	1.6e-05	9e-05	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Betamethasone—hematologic cancer	1.6e-05	9e-05	CcSEcCtD
Lomefloxacin—Dysgeusia—Epirubicin—hematologic cancer	1.59e-05	8.99e-05	CcSEcCtD
Lomefloxacin—Hypersensitivity—Triamcinolone—hematologic cancer	1.58e-05	8.93e-05	CcSEcCtD
Lomefloxacin—Nervousness—Epirubicin—hematologic cancer	1.58e-05	8.92e-05	CcSEcCtD
Lomefloxacin—Back pain—Epirubicin—hematologic cancer	1.58e-05	8.88e-05	CcSEcCtD
Lomefloxacin—Malaise—Methotrexate—hematologic cancer	1.57e-05	8.85e-05	CcSEcCtD
Lomefloxacin—Dizziness—Etoposide—hematologic cancer	1.57e-05	8.84e-05	CcSEcCtD
Lomefloxacin—Muscle spasms—Epirubicin—hematologic cancer	1.57e-05	8.83e-05	CcSEcCtD
Lomefloxacin—Vertigo—Methotrexate—hematologic cancer	1.56e-05	8.81e-05	CcSEcCtD
Lomefloxacin—Leukopenia—Methotrexate—hematologic cancer	1.56e-05	8.78e-05	CcSEcCtD
Lomefloxacin—TOP2A—Methyltestosterone—Prednisone—hematologic cancer	1.56e-05	0.00468	CbGdCrCtD
Lomefloxacin—Chills—Doxorubicin—hematologic cancer	1.55e-05	8.76e-05	CcSEcCtD
Lomefloxacin—Urticaria—Dexamethasone—hematologic cancer	1.55e-05	8.74e-05	CcSEcCtD
Lomefloxacin—Urticaria—Betamethasone—hematologic cancer	1.55e-05	8.74e-05	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Prednisone—hematologic cancer	1.55e-05	8.73e-05	CcSEcCtD
Lomefloxacin—Dizziness—Prednisolone—hematologic cancer	1.55e-05	8.72e-05	CcSEcCtD
Lomefloxacin—Arrhythmia—Doxorubicin—hematologic cancer	1.55e-05	8.72e-05	CcSEcCtD
Lomefloxacin—Asthenia—Triamcinolone—hematologic cancer	1.54e-05	8.7e-05	CcSEcCtD
Lomefloxacin—Abdominal pain—Dexamethasone—hematologic cancer	1.54e-05	8.7e-05	CcSEcCtD
Lomefloxacin—Abdominal pain—Betamethasone—hematologic cancer	1.54e-05	8.7e-05	CcSEcCtD
Lomefloxacin—Nausea—Cisplatin—hematologic cancer	1.54e-05	8.67e-05	CcSEcCtD
Lomefloxacin—Insomnia—Prednisone—hematologic cancer	1.54e-05	8.67e-05	CcSEcCtD
Lomefloxacin—Paraesthesia—Prednisone—hematologic cancer	1.53e-05	8.6e-05	CcSEcCtD
Lomefloxacin—Pruritus—Triamcinolone—hematologic cancer	1.52e-05	8.58e-05	CcSEcCtD
Lomefloxacin—TOP2A—Methyltestosterone—Prednisolone—hematologic cancer	1.52e-05	0.00457	CbGdCrCtD
Lomefloxacin—Cough—Methotrexate—hematologic cancer	1.52e-05	8.56e-05	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Epirubicin—hematologic cancer	1.51e-05	8.52e-05	CcSEcCtD
Lomefloxacin—Convulsion—Methotrexate—hematologic cancer	1.51e-05	8.5e-05	CcSEcCtD
Lomefloxacin—Vomiting—Etoposide—hematologic cancer	1.51e-05	8.5e-05	CcSEcCtD
Lomefloxacin—Anaemia—Epirubicin—hematologic cancer	1.51e-05	8.49e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—hematologic cancer	1.5e-05	0.000436	CbGpPWpGaD
Lomefloxacin—Agitation—Epirubicin—hematologic cancer	1.5e-05	8.44e-05	CcSEcCtD
Lomefloxacin—Dyspepsia—Prednisone—hematologic cancer	1.5e-05	8.43e-05	CcSEcCtD
Lomefloxacin—Rash—Etoposide—hematologic cancer	1.49e-05	8.43e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Etoposide—hematologic cancer	1.49e-05	8.42e-05	CcSEcCtD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.49e-05	0.000434	CbGpPWpGaD
Lomefloxacin—Headache—Etoposide—hematologic cancer	1.49e-05	8.37e-05	CcSEcCtD
Lomefloxacin—Flatulence—Doxorubicin—hematologic cancer	1.48e-05	8.37e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CDKN2A—hematologic cancer	1.48e-05	0.000432	CbGpPWpGaD
Lomefloxacin—Myalgia—Methotrexate—hematologic cancer	1.48e-05	8.35e-05	CcSEcCtD
Lomefloxacin—Arthralgia—Methotrexate—hematologic cancer	1.48e-05	8.35e-05	CcSEcCtD
Lomefloxacin—Chest pain—Methotrexate—hematologic cancer	1.48e-05	8.35e-05	CcSEcCtD
Lomefloxacin—Tension—Doxorubicin—hematologic cancer	1.48e-05	8.34e-05	CcSEcCtD
Lomefloxacin—Decreased appetite—Prednisone—hematologic cancer	1.48e-05	8.33e-05	CcSEcCtD
Lomefloxacin—Dysgeusia—Doxorubicin—hematologic cancer	1.48e-05	8.32e-05	CcSEcCtD
Lomefloxacin—Rash—Prednisolone—hematologic cancer	1.47e-05	8.31e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Prednisolone—hematologic cancer	1.47e-05	8.31e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1B—hematologic cancer	1.47e-05	0.000428	CbGpPWpGaD
Lomefloxacin—Malaise—Epirubicin—hematologic cancer	1.47e-05	8.28e-05	CcSEcCtD
Lomefloxacin—Fatigue—Prednisone—hematologic cancer	1.47e-05	8.26e-05	CcSEcCtD
Lomefloxacin—Headache—Prednisolone—hematologic cancer	1.47e-05	8.26e-05	CcSEcCtD
Lomefloxacin—Discomfort—Methotrexate—hematologic cancer	1.46e-05	8.25e-05	CcSEcCtD
Lomefloxacin—Nervousness—Doxorubicin—hematologic cancer	1.46e-05	8.25e-05	CcSEcCtD
Lomefloxacin—Vertigo—Epirubicin—hematologic cancer	1.46e-05	8.25e-05	CcSEcCtD
Lomefloxacin—Syncope—Epirubicin—hematologic cancer	1.46e-05	8.23e-05	CcSEcCtD
Lomefloxacin—Leukopenia—Epirubicin—hematologic cancer	1.46e-05	8.22e-05	CcSEcCtD
Lomefloxacin—Back pain—Doxorubicin—hematologic cancer	1.46e-05	8.22e-05	CcSEcCtD
Lomefloxacin—Constipation—Prednisone—hematologic cancer	1.45e-05	8.19e-05	CcSEcCtD
Lomefloxacin—Muscle spasms—Doxorubicin—hematologic cancer	1.45e-05	8.17e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—MDM2—hematologic cancer	1.44e-05	0.000419	CbGpPWpGaD
Lomefloxacin—Confusional state—Methotrexate—hematologic cancer	1.43e-05	8.07e-05	CcSEcCtD
Lomefloxacin—Loss of consciousness—Epirubicin—hematologic cancer	1.43e-05	8.07e-05	CcSEcCtD
Lomefloxacin—Dizziness—Triamcinolone—hematologic cancer	1.42e-05	8.02e-05	CcSEcCtD
Lomefloxacin—Cough—Epirubicin—hematologic cancer	1.42e-05	8.01e-05	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Methotrexate—hematologic cancer	1.42e-05	8.01e-05	CcSEcCtD
Lomefloxacin—Convulsion—Epirubicin—hematologic cancer	1.41e-05	7.96e-05	CcSEcCtD
Lomefloxacin—Nausea—Etoposide—hematologic cancer	1.41e-05	7.94e-05	CcSEcCtD
Lomefloxacin—Hypertension—Epirubicin—hematologic cancer	1.41e-05	7.93e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—hematologic cancer	1.4e-05	0.000408	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Prednisone—hematologic cancer	1.4e-05	7.9e-05	CcSEcCtD
Lomefloxacin—Asthenia—Betamethasone—hematologic cancer	1.4e-05	7.89e-05	CcSEcCtD
Lomefloxacin—Asthenia—Dexamethasone—hematologic cancer	1.4e-05	7.89e-05	CcSEcCtD
Lomefloxacin—Ill-defined disorder—Doxorubicin—hematologic cancer	1.4e-05	7.88e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ARNTL—hematologic cancer	1.4e-05	0.000407	CbGpPWpGaD
Lomefloxacin—SLC22A5—Transmembrane transport of small molecules—ALB—hematologic cancer	1.39e-05	0.000406	CbGpPWpGaD
Lomefloxacin—Anaemia—Doxorubicin—hematologic cancer	1.39e-05	7.85e-05	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Methotrexate—hematologic cancer	1.39e-05	7.84e-05	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Prednisone—hematologic cancer	1.39e-05	7.83e-05	CcSEcCtD
Lomefloxacin—Nausea—Prednisolone—hematologic cancer	1.39e-05	7.83e-05	CcSEcCtD
Lomefloxacin—Myalgia—Epirubicin—hematologic cancer	1.39e-05	7.82e-05	CcSEcCtD
Lomefloxacin—Arthralgia—Epirubicin—hematologic cancer	1.39e-05	7.82e-05	CcSEcCtD
Lomefloxacin—Chest pain—Epirubicin—hematologic cancer	1.39e-05	7.82e-05	CcSEcCtD
Lomefloxacin—Agitation—Doxorubicin—hematologic cancer	1.38e-05	7.81e-05	CcSEcCtD
Lomefloxacin—Anxiety—Epirubicin—hematologic cancer	1.38e-05	7.79e-05	CcSEcCtD
Lomefloxacin—Pruritus—Dexamethasone—hematologic cancer	1.38e-05	7.78e-05	CcSEcCtD
Lomefloxacin—Pruritus—Betamethasone—hematologic cancer	1.38e-05	7.78e-05	CcSEcCtD
Lomefloxacin—Skin disorder—Methotrexate—hematologic cancer	1.38e-05	7.78e-05	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Methotrexate—hematologic cancer	1.37e-05	7.74e-05	CcSEcCtD
Lomefloxacin—Discomfort—Epirubicin—hematologic cancer	1.37e-05	7.72e-05	CcSEcCtD
Lomefloxacin—Vomiting—Triamcinolone—hematologic cancer	1.37e-05	7.71e-05	CcSEcCtD
Lomefloxacin—Malaise—Doxorubicin—hematologic cancer	1.36e-05	7.66e-05	CcSEcCtD
Lomefloxacin—Rash—Triamcinolone—hematologic cancer	1.36e-05	7.65e-05	CcSEcCtD
Lomefloxacin—Dry mouth—Epirubicin—hematologic cancer	1.36e-05	7.64e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—CDKN1A—hematologic cancer	1.36e-05	0.000395	CbGpPWpGaD
Lomefloxacin—Dermatitis—Triamcinolone—hematologic cancer	1.35e-05	7.64e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—PHYH—hematologic cancer	1.35e-05	0.000395	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GMPS—hematologic cancer	1.35e-05	0.000395	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—FTCD—hematologic cancer	1.35e-05	0.000395	CbGpPWpGaD
Lomefloxacin—Vertigo—Doxorubicin—hematologic cancer	1.35e-05	7.63e-05	CcSEcCtD
Lomefloxacin—Anorexia—Methotrexate—hematologic cancer	1.35e-05	7.63e-05	CcSEcCtD
Lomefloxacin—Syncope—Doxorubicin—hematologic cancer	1.35e-05	7.62e-05	CcSEcCtD
Lomefloxacin—Urticaria—Prednisone—hematologic cancer	1.35e-05	7.61e-05	CcSEcCtD
Lomefloxacin—Leukopenia—Doxorubicin—hematologic cancer	1.35e-05	7.6e-05	CcSEcCtD
Lomefloxacin—Headache—Triamcinolone—hematologic cancer	1.35e-05	7.6e-05	CcSEcCtD
Lomefloxacin—Abdominal pain—Prednisone—hematologic cancer	1.34e-05	7.57e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR2—hematologic cancer	1.34e-05	0.000391	CbGpPWpGaD
Lomefloxacin—Confusional state—Epirubicin—hematologic cancer	1.34e-05	7.56e-05	CcSEcCtD
Lomefloxacin—Diarrhoea—Dexamethasone—hematologic cancer	1.34e-05	7.53e-05	CcSEcCtD
Lomefloxacin—Diarrhoea—Betamethasone—hematologic cancer	1.34e-05	7.53e-05	CcSEcCtD
Lomefloxacin—Oedema—Epirubicin—hematologic cancer	1.33e-05	7.49e-05	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Epirubicin—hematologic cancer	1.33e-05	7.49e-05	CcSEcCtD
Lomefloxacin—Hypotension—Methotrexate—hematologic cancer	1.33e-05	7.48e-05	CcSEcCtD
Lomefloxacin—Loss of consciousness—Doxorubicin—hematologic cancer	1.32e-05	7.47e-05	CcSEcCtD
Lomefloxacin—Cough—Doxorubicin—hematologic cancer	1.31e-05	7.41e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1B—hematologic cancer	1.31e-05	0.000383	CbGpPWpGaD
Lomefloxacin—Shock—Epirubicin—hematologic cancer	1.31e-05	7.37e-05	CcSEcCtD
Lomefloxacin—Convulsion—Doxorubicin—hematologic cancer	1.31e-05	7.36e-05	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Epirubicin—hematologic cancer	1.3e-05	7.34e-05	CcSEcCtD
Lomefloxacin—Hypertension—Doxorubicin—hematologic cancer	1.3e-05	7.33e-05	CcSEcCtD
Lomefloxacin—Tachycardia—Epirubicin—hematologic cancer	1.3e-05	7.31e-05	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Methotrexate—hematologic cancer	1.29e-05	7.3e-05	CcSEcCtD
Lomefloxacin—Skin disorder—Epirubicin—hematologic cancer	1.29e-05	7.28e-05	CcSEcCtD
Lomefloxacin—Dizziness—Dexamethasone—hematologic cancer	1.29e-05	7.28e-05	CcSEcCtD
Lomefloxacin—Dizziness—Betamethasone—hematologic cancer	1.29e-05	7.28e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—EP300—hematologic cancer	1.29e-05	0.000376	CbGpPWpGaD
Lomefloxacin—Hyperhidrosis—Epirubicin—hematologic cancer	1.28e-05	7.24e-05	CcSEcCtD
Lomefloxacin—Insomnia—Methotrexate—hematologic cancer	1.28e-05	7.24e-05	CcSEcCtD
Lomefloxacin—Arthralgia—Doxorubicin—hematologic cancer	1.28e-05	7.23e-05	CcSEcCtD
Lomefloxacin—Chest pain—Doxorubicin—hematologic cancer	1.28e-05	7.23e-05	CcSEcCtD
Lomefloxacin—Myalgia—Doxorubicin—hematologic cancer	1.28e-05	7.23e-05	CcSEcCtD
Lomefloxacin—Anxiety—Doxorubicin—hematologic cancer	1.28e-05	7.21e-05	CcSEcCtD
Lomefloxacin—Nausea—Triamcinolone—hematologic cancer	1.28e-05	7.2e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—hematologic cancer	1.28e-05	0.000372	CbGpPWpGaD
Lomefloxacin—Paraesthesia—Methotrexate—hematologic cancer	1.28e-05	7.19e-05	CcSEcCtD
Lomefloxacin—Discomfort—Doxorubicin—hematologic cancer	1.27e-05	7.15e-05	CcSEcCtD
Lomefloxacin—Anorexia—Epirubicin—hematologic cancer	1.27e-05	7.14e-05	CcSEcCtD
Lomefloxacin—Dyspnoea—Methotrexate—hematologic cancer	1.27e-05	7.14e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ABCC3—hematologic cancer	1.26e-05	0.000368	CbGpPWpGaD
Lomefloxacin—Somnolence—Methotrexate—hematologic cancer	1.26e-05	7.12e-05	CcSEcCtD
Lomefloxacin—Dry mouth—Doxorubicin—hematologic cancer	1.25e-05	7.07e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CCND1—hematologic cancer	1.25e-05	0.000365	CbGpPWpGaD
Lomefloxacin—Hypersensitivity—Prednisone—hematologic cancer	1.25e-05	7.06e-05	CcSEcCtD
Lomefloxacin—Dyspepsia—Methotrexate—hematologic cancer	1.25e-05	7.05e-05	CcSEcCtD
Lomefloxacin—Hypotension—Epirubicin—hematologic cancer	1.24e-05	7e-05	CcSEcCtD
Lomefloxacin—Vomiting—Dexamethasone—hematologic cancer	1.24e-05	7e-05	CcSEcCtD
Lomefloxacin—Vomiting—Betamethasone—hematologic cancer	1.24e-05	7e-05	CcSEcCtD
Lomefloxacin—Confusional state—Doxorubicin—hematologic cancer	1.24e-05	6.99e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—SMPD3—hematologic cancer	1.24e-05	0.000361	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	1.24e-05	0.00036	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Methotrexate—hematologic cancer	1.23e-05	6.96e-05	CcSEcCtD
Lomefloxacin—Rash—Dexamethasone—hematologic cancer	1.23e-05	6.94e-05	CcSEcCtD
Lomefloxacin—Rash—Betamethasone—hematologic cancer	1.23e-05	6.94e-05	CcSEcCtD
Lomefloxacin—Anaphylactic shock—Doxorubicin—hematologic cancer	1.23e-05	6.93e-05	CcSEcCtD
Lomefloxacin—Oedema—Doxorubicin—hematologic cancer	1.23e-05	6.93e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Betamethasone—hematologic cancer	1.23e-05	6.93e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Dexamethasone—hematologic cancer	1.23e-05	6.93e-05	CcSEcCtD
Lomefloxacin—Fatigue—Methotrexate—hematologic cancer	1.22e-05	6.9e-05	CcSEcCtD
Lomefloxacin—Headache—Betamethasone—hematologic cancer	1.22e-05	6.89e-05	CcSEcCtD
Lomefloxacin—Headache—Dexamethasone—hematologic cancer	1.22e-05	6.89e-05	CcSEcCtD
Lomefloxacin—Asthenia—Prednisone—hematologic cancer	1.22e-05	6.87e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—CDKN1A—hematologic cancer	1.21e-05	0.000353	CbGpPWpGaD
Lomefloxacin—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.21e-05	6.83e-05	CcSEcCtD
Lomefloxacin—Shock—Doxorubicin—hematologic cancer	1.21e-05	6.82e-05	CcSEcCtD
Lomefloxacin—Thrombocytopenia—Doxorubicin—hematologic cancer	1.2e-05	6.79e-05	CcSEcCtD
Lomefloxacin—Pruritus—Prednisone—hematologic cancer	1.2e-05	6.78e-05	CcSEcCtD
Lomefloxacin—Insomnia—Epirubicin—hematologic cancer	1.2e-05	6.78e-05	CcSEcCtD
Lomefloxacin—Tachycardia—Doxorubicin—hematologic cancer	1.2e-05	6.77e-05	CcSEcCtD
Lomefloxacin—Skin disorder—Doxorubicin—hematologic cancer	1.19e-05	6.73e-05	CcSEcCtD
Lomefloxacin—Paraesthesia—Epirubicin—hematologic cancer	1.19e-05	6.73e-05	CcSEcCtD
Lomefloxacin—Hyperhidrosis—Doxorubicin—hematologic cancer	1.19e-05	6.7e-05	CcSEcCtD
Lomefloxacin—Dyspnoea—Epirubicin—hematologic cancer	1.18e-05	6.68e-05	CcSEcCtD
Lomefloxacin—Somnolence—Epirubicin—hematologic cancer	1.18e-05	6.66e-05	CcSEcCtD
Lomefloxacin—Anorexia—Doxorubicin—hematologic cancer	1.17e-05	6.61e-05	CcSEcCtD
Lomefloxacin—Feeling abnormal—Methotrexate—hematologic cancer	1.17e-05	6.6e-05	CcSEcCtD
Lomefloxacin—Dyspepsia—Epirubicin—hematologic cancer	1.17e-05	6.6e-05	CcSEcCtD
Lomefloxacin—Diarrhoea—Prednisone—hematologic cancer	1.16e-05	6.56e-05	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Methotrexate—hematologic cancer	1.16e-05	6.55e-05	CcSEcCtD
Lomefloxacin—Nausea—Betamethasone—hematologic cancer	1.16e-05	6.53e-05	CcSEcCtD
Lomefloxacin—Nausea—Dexamethasone—hematologic cancer	1.16e-05	6.53e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MAPK3—hematologic cancer	1.16e-05	0.000337	CbGpPWpGaD
Lomefloxacin—Decreased appetite—Epirubicin—hematologic cancer	1.16e-05	6.51e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	1.16e-05	0.000337	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle—EP300—hematologic cancer	1.15e-05	0.000336	CbGpPWpGaD
Lomefloxacin—Hypotension—Doxorubicin—hematologic cancer	1.15e-05	6.48e-05	CcSEcCtD
Lomefloxacin—Fatigue—Epirubicin—hematologic cancer	1.15e-05	6.46e-05	CcSEcCtD
Lomefloxacin—Constipation—Epirubicin—hematologic cancer	1.14e-05	6.41e-05	CcSEcCtD
Lomefloxacin—Urticaria—Methotrexate—hematologic cancer	1.13e-05	6.36e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	1.13e-05	0.000328	CbGpPWpGaD
Lomefloxacin—TOP2A—Cell Cycle, Mitotic—MYC—hematologic cancer	1.12e-05	0.000327	CbGpPWpGaD
Lomefloxacin—Dizziness—Prednisone—hematologic cancer	1.12e-05	6.34e-05	CcSEcCtD
Lomefloxacin—Abdominal pain—Methotrexate—hematologic cancer	1.12e-05	6.33e-05	CcSEcCtD
Lomefloxacin—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.12e-05	6.32e-05	CcSEcCtD
Lomefloxacin—Insomnia—Doxorubicin—hematologic cancer	1.11e-05	6.27e-05	CcSEcCtD
Lomefloxacin—Paraesthesia—Doxorubicin—hematologic cancer	1.1e-05	6.23e-05	CcSEcCtD
Lomefloxacin—Dyspnoea—Doxorubicin—hematologic cancer	1.1e-05	6.18e-05	CcSEcCtD
Lomefloxacin—Feeling abnormal—Epirubicin—hematologic cancer	1.1e-05	6.17e-05	CcSEcCtD
Lomefloxacin—Somnolence—Doxorubicin—hematologic cancer	1.09e-05	6.16e-05	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	1.09e-05	0.000317	CbGpPWpGaD
Lomefloxacin—Gastrointestinal pain—Epirubicin—hematologic cancer	1.09e-05	6.13e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—B3GAT1—hematologic cancer	1.08e-05	0.000316	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ASNS—hematologic cancer	1.08e-05	0.000316	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—DCK—hematologic cancer	1.08e-05	0.000316	CbGpPWpGaD
Lomefloxacin—Dyspepsia—Doxorubicin—hematologic cancer	1.08e-05	6.1e-05	CcSEcCtD
Lomefloxacin—Vomiting—Prednisone—hematologic cancer	1.08e-05	6.09e-05	CcSEcCtD
Lomefloxacin—Rash—Prednisone—hematologic cancer	1.07e-05	6.04e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Prednisone—hematologic cancer	1.07e-05	6.04e-05	CcSEcCtD
Lomefloxacin—Decreased appetite—Doxorubicin—hematologic cancer	1.07e-05	6.03e-05	CcSEcCtD
Lomefloxacin—Headache—Prednisone—hematologic cancer	1.06e-05	6e-05	CcSEcCtD
Lomefloxacin—Fatigue—Doxorubicin—hematologic cancer	1.06e-05	5.98e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	1.06e-05	0.000308	CbGpPWpGaD
Lomefloxacin—Urticaria—Epirubicin—hematologic cancer	1.06e-05	5.95e-05	CcSEcCtD
Lomefloxacin—Constipation—Doxorubicin—hematologic cancer	1.05e-05	5.93e-05	CcSEcCtD
Lomefloxacin—Abdominal pain—Epirubicin—hematologic cancer	1.05e-05	5.92e-05	CcSEcCtD
Lomefloxacin—Hypersensitivity—Methotrexate—hematologic cancer	1.05e-05	5.9e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—MAPK3—hematologic cancer	1.03e-05	0.000301	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HDC—hematologic cancer	1.03e-05	0.000299	CbGpPWpGaD
Lomefloxacin—Asthenia—Methotrexate—hematologic cancer	1.02e-05	5.74e-05	CcSEcCtD
Lomefloxacin—ABCC2—Transmembrane transport of small molecules—ALB—hematologic cancer	1.02e-05	0.000297	CbGpPWpGaD
Lomefloxacin—Feeling abnormal—Doxorubicin—hematologic cancer	1.01e-05	5.71e-05	CcSEcCtD
Lomefloxacin—Nausea—Prednisone—hematologic cancer	1.01e-05	5.69e-05	CcSEcCtD
Lomefloxacin—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.01e-05	5.67e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—MYC—hematologic cancer	1.01e-05	0.000293	CbGpPWpGaD
Lomefloxacin—Pruritus—Methotrexate—hematologic cancer	1e-05	5.67e-05	CcSEcCtD
Lomefloxacin—Hypersensitivity—Epirubicin—hematologic cancer	9.79e-06	5.52e-05	CcSEcCtD
Lomefloxacin—Urticaria—Doxorubicin—hematologic cancer	9.77e-06	5.51e-05	CcSEcCtD
Lomefloxacin—Abdominal pain—Doxorubicin—hematologic cancer	9.72e-06	5.48e-05	CcSEcCtD
Lomefloxacin—Diarrhoea—Methotrexate—hematologic cancer	9.72e-06	5.48e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	9.57e-06	0.000279	CbGpPWpGaD
Lomefloxacin—Asthenia—Epirubicin—hematologic cancer	9.54e-06	5.38e-05	CcSEcCtD
Lomefloxacin—Pruritus—Epirubicin—hematologic cancer	9.4e-06	5.3e-05	CcSEcCtD
Lomefloxacin—Dizziness—Methotrexate—hematologic cancer	9.39e-06	5.29e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—CDA—hematologic cancer	9.39e-06	0.000274	CbGpPWpGaD
Lomefloxacin—Diarrhoea—Epirubicin—hematologic cancer	9.09e-06	5.13e-05	CcSEcCtD
Lomefloxacin—Hypersensitivity—Doxorubicin—hematologic cancer	9.06e-06	5.11e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—PC—hematologic cancer	9.04e-06	0.000263	CbGpPWpGaD
Lomefloxacin—Vomiting—Methotrexate—hematologic cancer	9.03e-06	5.09e-05	CcSEcCtD
Lomefloxacin—Rash—Methotrexate—hematologic cancer	8.95e-06	5.05e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Methotrexate—hematologic cancer	8.95e-06	5.04e-05	CcSEcCtD
Lomefloxacin—Headache—Methotrexate—hematologic cancer	8.9e-06	5.02e-05	CcSEcCtD
Lomefloxacin—Asthenia—Doxorubicin—hematologic cancer	8.82e-06	4.97e-05	CcSEcCtD
Lomefloxacin—Dizziness—Epirubicin—hematologic cancer	8.79e-06	4.96e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—SLC35B2—hematologic cancer	8.73e-06	0.000254	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GBA—hematologic cancer	8.73e-06	0.000254	CbGpPWpGaD
Lomefloxacin—Pruritus—Doxorubicin—hematologic cancer	8.7e-06	4.91e-05	CcSEcCtD
Lomefloxacin—Vomiting—Epirubicin—hematologic cancer	8.45e-06	4.76e-05	CcSEcCtD
Lomefloxacin—Nausea—Methotrexate—hematologic cancer	8.44e-06	4.76e-05	CcSEcCtD
Lomefloxacin—Diarrhoea—Doxorubicin—hematologic cancer	8.41e-06	4.74e-05	CcSEcCtD
Lomefloxacin—Rash—Epirubicin—hematologic cancer	8.38e-06	4.72e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Epirubicin—hematologic cancer	8.37e-06	4.72e-05	CcSEcCtD
Lomefloxacin—Headache—Epirubicin—hematologic cancer	8.33e-06	4.69e-05	CcSEcCtD
Lomefloxacin—TOP2A—Cell Cycle—TP53—hematologic cancer	8.25e-06	0.00024	CbGpPWpGaD
Lomefloxacin—Dizziness—Doxorubicin—hematologic cancer	8.13e-06	4.58e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—MTAP—hematologic cancer	7.98e-06	0.000233	CbGpPWpGaD
Lomefloxacin—Nausea—Epirubicin—hematologic cancer	7.89e-06	4.45e-05	CcSEcCtD
Lomefloxacin—Vomiting—Doxorubicin—hematologic cancer	7.82e-06	4.41e-05	CcSEcCtD
Lomefloxacin—Rash—Doxorubicin—hematologic cancer	7.75e-06	4.37e-05	CcSEcCtD
Lomefloxacin—Dermatitis—Doxorubicin—hematologic cancer	7.75e-06	4.37e-05	CcSEcCtD
Lomefloxacin—Headache—Doxorubicin—hematologic cancer	7.7e-06	4.34e-05	CcSEcCtD
Lomefloxacin—Nausea—Doxorubicin—hematologic cancer	7.3e-06	4.12e-05	CcSEcCtD
Lomefloxacin—CYP1A2—Metabolism—FHL2—hematologic cancer	7.12e-06	0.000207	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AGRN—hematologic cancer	6.98e-06	0.000203	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HMMR—hematologic cancer	6.62e-06	0.000193	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—IDH2—hematologic cancer	6.62e-06	0.000193	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.24e-06	0.000182	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ARNTL—hematologic cancer	6.22e-06	0.000181	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ACP5—hematologic cancer	6.05e-06	0.000176	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CA9—hematologic cancer	6.05e-06	0.000176	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOR2—hematologic cancer	5.97e-06	0.000174	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—IDH1—hematologic cancer	5.69e-06	0.000166	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCC3—hematologic cancer	5.62e-06	0.000164	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—TXN—hematologic cancer	5.62e-06	0.000164	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTO1—hematologic cancer	5.62e-06	0.000164	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SPHK1—hematologic cancer	5.5e-06	0.00016	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—UGT1A1—hematologic cancer	5.29e-06	0.000154	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SLC22A1—hematologic cancer	5.14e-06	0.00015	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CRABP1—hematologic cancer	5.14e-06	0.00015	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALOX5—hematologic cancer	5.01e-06	0.000146	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NUP98—hematologic cancer	4.86e-06	0.000141	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ADCY7—hematologic cancer	4.71e-06	0.000137	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOA3—hematologic cancer	4.71e-06	0.000137	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NUP214—hematologic cancer	4.68e-06	0.000136	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.63e-06	0.000135	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCG2—hematologic cancer	4.59e-06	0.000134	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTR—hematologic cancer	4.59e-06	0.000134	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ENO2—hematologic cancer	4.5e-06	0.000131	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTT1—hematologic cancer	4.36e-06	0.000127	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.29e-06	0.000125	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—SDC1—hematologic cancer	4.26e-06	0.000124	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.07e-06	0.000119	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.02e-06	0.000117	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.85e-06	0.000112	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CD44—hematologic cancer	3.62e-06	0.000106	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NQO1—hematologic cancer	3.62e-06	0.000106	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.55e-06	0.000103	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CYCS—hematologic cancer	3.43e-06	9.99e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—HSP90AA1—hematologic cancer	3.41e-06	9.93e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.07e-06	8.94e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTP1—hematologic cancer	3.02e-06	8.81e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.92e-06	8.52e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ABCB1—hematologic cancer	2.86e-06	8.34e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—GSTM1—hematologic cancer	2.78e-06	8.09e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—NCOR1—hematologic cancer	2.78e-06	8.09e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—MTHFR—hematologic cancer	2.46e-06	7.15e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.16e-06	6.3e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CG—hematologic cancer	2.06e-06	6.01e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—CREBBP—hematologic cancer	1.91e-06	5.57e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CD—hematologic cancer	1.81e-06	5.28e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—ALB—hematologic cancer	1.79e-06	5.22e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3R1—hematologic cancer	1.71e-06	4.99e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CB—hematologic cancer	1.58e-06	4.61e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PTEN—hematologic cancer	1.37e-06	3.98e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—EP300—hematologic cancer	1.3e-06	3.8e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—PIK3CA—hematologic cancer	9.64e-07	2.81e-05	CbGpPWpGaD
Lomefloxacin—CYP1A2—Metabolism—AKT1—hematologic cancer	7.87e-07	2.29e-05	CbGpPWpGaD
